ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Stryker Corp

Stryker Corp (SYK)

365.66
1.56
(0.43%)
마감 11 1월 6:00AM
365.66
0.00
(0.00%)
시간외 거래: 9:58AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
365.66
매수가
-
매도가
-
거래량
1,313,295
361.16 일간 변동폭 368.82
304.00 52주 범위 398.20
market_cap
전일 종가
364.10
개장가
361.62
최근 거래 시간
89
@
365
마지막 거래 시간
재정 규모
US$ 479,501,944
VWAP
365.1137
평균 볼륨(3m)
1,288,602
발행 주식
381,215,773
배당수익률
0.92%
주가수익률
44.04
주당순이익(EPS)
8.3
매출
20.5B
순이익
3.17B

Stryker Corp 정보

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. St... Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Nearly one fourth of Stryker's total revenue currently comes from outside the United States. 더 보기

섹터
Surgical,med Instr,apparatus
산업
Surgical,med Instr,apparatus
웹사이트
본부
Plymouth, Michigan, USA
설립됨
-
Stryker Corp is listed in the Surgical,med Instr,apparatus sector of the 뉴욕 증권거래소 with ticker SYK. The last closing price for Stryker was US$364.10. Over the last year, Stryker shares have traded in a share price range of US$ 304.00 to US$ 398.20.

Stryker currently has 381,215,773 shares in issue. The market capitalisation of Stryker is US$138.80 billion. Stryker has a price to earnings ratio (PE ratio) of 44.04.

Stryker (SYK) 옵션 플로우 요약

전체 흐름

약세

순 프리미엄

-686k

Calls / Puts

30.00%

매수 / 매도

200.00%

OTM / ITM

18.18%

Sweeps 비율

0.00%

SYK 최신 뉴스

Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment

Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) --  Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all...

Stryker to announce financial results for its fourth quarter and full year 2024

Portage, Michigan, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its fourth quarter and full year 2024 on Tuesday, January 28, 2025.  A...

Stryker declares an $0.84 per share quarterly dividend

Portage, Michigan, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable January 31, 2025 to...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
14.691.29927694822360.97365.82351.851385034359.98743577CS
4-9.96-2.65161599489375.62376.485351.851258875363.66231618CS
124.511.248788592361.15398.2351.28571288602373.22506465CS
2630.088.96358543417335.58398.2314.931229006358.18527581CS
5260.6619.8885245902305398.23041259139347.88766929CS
156103.4639.4584286804262.2398.2188.841361825283.89084235CS
260152.9871.9296595825212.68398.2124.541378449257.20347405CS

SYK - Frequently Asked Questions (FAQ)

What is the current Stryker share price?
The current share price of Stryker is US$ 365.66
How many Stryker shares are in issue?
Stryker has 381,215,773 shares in issue
What is the market cap of Stryker?
The market capitalisation of Stryker is USD 138.8B
What is the 1 year trading range for Stryker share price?
Stryker has traded in the range of US$ 304.00 to US$ 398.20 during the past year
What is the PE ratio of Stryker?
The price to earnings ratio of Stryker is 44.04
What is the cash to sales ratio of Stryker?
The cash to sales ratio of Stryker is 6.8
What is the reporting currency for Stryker?
Stryker reports financial results in USD
What is the latest annual turnover for Stryker?
The latest annual turnover of Stryker is USD 20.5B
What is the latest annual profit for Stryker?
The latest annual profit of Stryker is USD 3.17B
What is the registered address of Stryker?
The registered address for Stryker is 40600 ANN ARBOR RD E, SUITE 201, PLYMOUTH, MICHIGAN, 48170
What is the Stryker website address?
The website address for Stryker is www.stryker.com
Which industry sector does Stryker operate in?
Stryker operates in the SURGICAL,MED INSTR,APPARATUS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AMPXAmprius Technologies Inc
US$ 3.58
(18.15%)
9.45M
EVCEntravision Communications Corp
US$ 2.65
(16.23%)
1.23M
SSLSasol Ltd
US$ 5.07
(14.71%)
2.45M
OPFIOppFi Inc
US$ 9.285
(12.96%)
4.96M
SVVSavers Value Village Inc
US$ 10.4525
(11.55%)
956.76k
ALURAllurion Technologies Inc
US$ 3.80
(-47.51%)
229.92k
MCYMercury General Corp
US$ 48.68
(-19.80%)
3.49M
SESSES AI Corporation
US$ 1.265
(-18.39%)
18.16M
STZConstellation Brands Inc
US$ 181.81
(-17.09%)
8.7M
GROVGrove Collaborative Holdings Inc
US$ 1.46
(-17.05%)
885.79k
FUBOfuboTV
US$ 5.11
(-4.49%)
100.46M
QBTSD Wave Quantum Inc
US$ 5.765
(-5.49%)
88.93M
PCGPG&E Corporation
US$ 17.16
(-10.86%)
74.31M
FFord Motor Company
US$ 9.65
(-0.92%)
73.37M
IONQIonQ Inc
US$ 32.33
(6.88%)
69.77M

SYK Discussion

게시물 보기
Monksdream Monksdream 2 월 전
SYK, new 52 week high
👍️0
LORTAP KCOTS LORTAP KCOTS 2 월 전
Hasn't broken down yet. Patiently waiting for the cycle to start again. I'll bet this gets down below $300 before years end.
👍️0
Monksdream Monksdream 4 월 전
SYK new 52=week high
👍️0
LORTAP KCOTS LORTAP KCOTS 8 월 전
I’ll start setting my buys for $292.00, hopefully it does the classic retrace after earnings
👍️0
Monksdream Monksdream 8 월 전
SYK 10Q due 4/30
👍️0
Monksdream Monksdream 10 월 전
SYK new 52 week hi
👍️0
LORTAP KCOTS LORTAP KCOTS 11 월 전
Crazy
👍️0
Monksdream Monksdream 11 월 전
SYK new 52 week high
👍️0
LORTAP KCOTS LORTAP KCOTS 11 월 전
Crazy especially because there are a ton of insiders selling.
My buy back in price is at $270 now.
Might be a while before this goes back down 20%, but historically it will at some point..
👍️0
Monksdream Monksdream 11 월 전
SYK new 52 week high
👍️0
LORTAP KCOTS LORTAP KCOTS 11 월 전
New 52!!
Reload at 270 when the new higher low happens.
👍️0
LORTAP KCOTS LORTAP KCOTS 12 월 전
Love to see it consistently do it’s magic
👍️0
Monksdream Monksdream 12 월 전
SYK new 52 week high
👍️0
Monksdream Monksdream 1 년 전
SYK new 52 week high
👍️0
LORTAP KCOTS LORTAP KCOTS 1 년 전
Thank you SYK..
Another $52,000 profit in a quick 1 month flip.
👍️0
LORTAP KCOTS LORTAP KCOTS 3 년 전
Gonna get another 1000 shares on Monday
👍️0
LORTAP KCOTS LORTAP KCOTS 3 년 전
Bought a ton at $250
👍️0
LORTAP KCOTS LORTAP KCOTS 3 년 전
Started buying in at $257.25.
Getting some $255 shares today as well.
👍️0
LORTAP KCOTS LORTAP KCOTS 3 년 전
Gonna put in buy orders at $239, stupid markets about to roll over and this will be a safe entrance
👍️0
larry77 larry77 3 년 전
has everyone gone to sleep on this? WTF?
👍️0
LORTAP KCOTS LORTAP KCOTS 3 년 전
Sold 272.12, waiting to reload at $245
Made $33,000 last trade.
👍️0
LORTAP KCOTS LORTAP KCOTS 3 년 전
Got filled 249 today, ready sell orders to unload at 269 again..
👍️0
LORTAP KCOTS LORTAP KCOTS 3 년 전
Made $13,000 on SYK trade.
Reloading at $250
👍️0
LORTAP KCOTS LORTAP KCOTS 3 년 전
Picked up 1000 shares@258.50, let’s roll this into some bank at $278.50!!!
👍️0
LORTAP KCOTS LORTAP KCOTS 5 년 전
Murder on the wall street this week
👍️0
LORTAP KCOTS LORTAP KCOTS 5 년 전
Crushed today.
👍️0
flyonthewall flyonthewall 5 년 전
I agree bro. Check out SECI only 306,000 shares exist and a multi billion settlement deadline is scheduled by the Judge for February 7, 2020 otherwise Trial starts in May of 2020. Literally Billions on the line here. Just a 1 Billion Dollar Judgement or Settlement would create 1 share with an approximate Value of $3,200. A perfect storm is happening here for a massive payout on technology that was stolen and intended to save FireFighters lives giving us real time GPS Tracking and VoIP Communications.
👍️0
LORTAP KCOTS LORTAP KCOTS 5 년 전
The best secret stock to keep long term
👍️0
flyonthewall flyonthewall 5 년 전
Good to know. Yes that is also what I figured. This company produces amazing medical devices that there will always be a demand for in the Emergency Medical Services sector.
👍️0
Striker77 Striker77 5 년 전
Its always a great hold. Worth at least 220 right now. Only down because some didnt like the acquisition last week.
👍️0
flyonthewall flyonthewall 5 년 전
SYK going higher from here longs ? I have December 210 calls. Anyone have ideas on how SYK should do on this upcoming earnings ?
👍️0
LORTAP KCOTS LORTAP KCOTS 5 년 전
Sold a trading position at $210.50, will buy back at $192.50
That’s the plan, as I bought the shares at $175, 3 months ago.
👍️0
pontiacg6 pontiacg6 6 년 전
Former MAKO CEO JOINS TITAN MEDICAL - TICKER TMDI

https://apple.news/AgYXFxFsEROmMHtrBEJGGFQ

MAKO GOT BOUGHT BY STRYKER MAYBE TMDI NEXT
👍️0
LORTAP KCOTS LORTAP KCOTS 6 년 전
Boom another all time high!
👍️0
LORTAP KCOTS LORTAP KCOTS 6 년 전
All time high again
👍️0
PennyStock Alert PennyStock Alert 6 년 전
Almost all time high
👍️0
PennyStock Alert PennyStock Alert 6 년 전
YIELD GROWTH Announces Healthy Planet Canada, an Independent Health and Wellness Company with 24 Ontario Retail Locations
👍️0
PennyStock Alert PennyStock Alert 6 년 전
Stryker acquires Arrinex

Source: GlobeNewswire Inc.

Stryker (NYSE:SYK) announced today it has completed the acquisition of Arrinex, Inc., a medical device company headquartered in Menlo Park, California, that has developed ClariFix®, a novel cryoablation technology for the treatment of chronic rhinitis. This condition, which affects over 24 million people in the U.S. each year, may cause runny nose, congestion, sneezing and nasal itching. Arrinex, which was founded in 2013, began commercializing ClariFix in late 2017 in the U.S. ClariFix further expands Stryker’s Ear, Nose and Throat (ENT) portfolio with a unique product to address a large, underpenetrated segment of the ENT market where Stryker does not currently compete.
“The acquisition of Arrinex is highly complementary to Stryker’s ENT portfolio, which is part of our Neurotechnology business,” said Spencer Stiles, Stryker’s Group President, Neurotechnology, Instruments and Spine. “This acquisition aligns with our focus on providing ENT physicians with new technologies that deliver more treatment options and better patient outcomes.”

Forward-looking statements
👍️0
PennyStock Alert PennyStock Alert 6 년 전
Small dip
👍️0
LORTAP KCOTS LORTAP KCOTS 6 년 전
Another all time high!
👍️0
LORTAP KCOTS LORTAP KCOTS 6 년 전
And another one
👍️0
LORTAP KCOTS LORTAP KCOTS 6 년 전
New 52 week high!
👍️0
LORTAP KCOTS LORTAP KCOTS 6 년 전
Awesome day!
👍️0
LORTAP KCOTS LORTAP KCOTS 7 년 전
New 52 week highs
👍️0
LORTAP KCOTS LORTAP KCOTS 7 년 전
Up $11 boom
👍️0
LORTAP KCOTS LORTAP KCOTS 7 년 전
Got a bunch of shares yesterday for cheap..!
Now those will be up $10 in the next week.
👍️0
LORTAP KCOTS LORTAP KCOTS 7 년 전
New all time high
👍️0
stealthways stealthways 8 년 전
think Stryker has been very complacent about emerging tech ,mainly due to its leading strength in the Ortho segment (this is not uncommon in various industries and the skeletons of similarly over confident companies are littered) --- and has failed to see how significant the dangers are of transformational tech. The bashers of the AMDA stock, don't kid yourself, has also affected the Stryker over confidence with their own tech.. "Asleep at the switch" comes to mind....

Lets assume that Stryker, for what ever reason, "wakes up", from its tech hibernation, and see that AMDA is cleaning the books, auditing assets etc, and other hallmarks of a potential sale. Lets further assume, they understand how AMDA tech would likely help Zimmer take many Billions of their revenue away over the next 5 to 10 years and add incremental new revenue, from new sources, to Zimmer..
If you look at Strykers history, it looks to me to have more experience than Zimmer at growing by acquisition ... Even if Stryker has some kind of relationship with Zimmer currently likely this would be superficial. Anyways, based on these assumptions, why would Stryker sit back and let this deal happen with no interference (i.e. competing bid) from it .... even if they know of the personal connections between AMDA and Zimmer. So for example lets says Stryker calculates an AMDA sale to Zimmer would take $5 Billion off the Present Value (roughly equal to market cap) of Stryker.. and lets say Zimmer trys to low ball a $100 million bid for AMDA... Under this scenario, no matter what relationships are, it would make no sense for Stryker to just sit back and let this deal happen with no response. Even if Stryker thinks Zimmer may potentially outbid them , its better for Stryker to have Zimmer pay up at least , if they do succeed.

Bottom line is Stryker needs to wake up to emerging tech and protect their future by trying to own the tech at AMDA....The bashing and manipulation of AMDA hides the true value, and danger if in the hand of a competitor, of the technology..time is of the essence...
👍️0
stealthways stealthways 8 년 전
Amedica books have been recently getting cleaned up and assets audited at Amedica, prepping for a sale, so Stryker could be successful in a quick purchase of Amedica. Japan approval is coming and China is ready also... Lobo needs to give this a priority in Business Development..
👍️0
stealthways stealthways 8 년 전
Lobo needs to act quick ....Stryker has a chance to acquire Amedica and its tech before Zimmer Biomet. If Stryker, drops the ball, and allows Zimmer to get Amedica, with world wide patents for its new SiNi, 3-D printing tech, main asian markets near approval, anti-infective properties, and many more advantages, Zimmer will be a tough night in Hip-knee, and gain share in spine .... It is simple for Stryker to block Zimmer, if they act quick.... Zimmer is preparing now to acquire this tech but Stryker , by using its superior M&A skills can be quicker and block this threat ....
👍️0

최근 히스토리

Delayed Upgrade Clock